Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-05-11

Clinical Trial Update: 3D Tissue Engineered Bone Equivalent for Treatment of Traumatic Bone Defects [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on a 3D tissue engineered bone substitute for traumatic bone defects, listed as Phase 1/Phase 2, sponsored by A.A. Partners, LLC; current …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: A.A. Partners, LLC | Conditions: Bone Defects | Phase 1, Phase 2 | Status: UNKNOWN